BeiGene Market Cap

BeiGene has a market cap or net worth of 188.39 billion as of January 30, 2025. Its market cap has increased by 32.85% in one year.

Market Cap

188.39B

Enterprise Value

175.44B

Revenue

26.04B

Ranking

n/a

PE Ratio

n/a

Stock Price

138.20

Market Cap Chart

Since February 3, 2016, BeiGene's market cap has increased from 6.70B to 188.39B, an increase of 2,713.08%. That is a compound annual growth rate of 44.90%.

Market Cap History

Date	Market Cap	% Change
Jan 30, 2025	188.39B	23.32%
Dec 31, 2024	152.77B	4.09%
Dec 29, 2023	146.76B	-17.60%
Dec 30, 2022	178.11B	-17.96%
Dec 31, 2021	217.12B	19.19%
Dec 31, 2020	182.15B	130.77%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Hansoh Pharmaceutical Group Company	106.11B
JD Health International	102.51B
WuXi Biologics	75.46B
Sinopharm Group	64.13B
Alibaba Health Information Technology	58.05B
Akeso	54.62B
Innovent Biologics	54.14B
CSPC Pharmaceutical Group	51.30B

Market Cap Rankings